Nomura Asset Management International’s Amicus Therapeutics FOLD Stock Holding History

Nomura Asset Management International’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,559,972	Closed	-$51.5M	–	1373
2026 Q1	$51.5M	Sell	3,559,972 -1,509,618	-30%	-$21.6M	0.09%	321
2025 Q4	$72.2M	Buy	+5,069,590	New	+$49.8M	0.11%	248

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Nomura Asset Management International's FOLD Position: Q2 2026 in Review

Nomura Asset Management International sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 3,559,972 shares — an estimated $51.5M sold.

Nomura Asset Management International first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $72.2M in Q4 2025. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Nomura Asset Management International reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Nomura Asset Management International sold 3,559,972 Amicus Therapeutics shares in Q2 2026, an estimated $51.5M.
Nomura Asset Management International first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
Nomura Asset Management International's Amicus Therapeutics position peaked at $72.2M in Q4 2025.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.